Parallel targeted and non-targeted quantitative analysis of steroids in human serum and peritoneal fluid by liquid chromatography high-resolution mass spectrometry.
Dienogest
High resolution
LC–MS
Menstrual cycle
Peritoneal fluid
Serum
Steroids
Journal
Analytical and bioanalytical chemistry
ISSN: 1618-2650
Titre abrégé: Anal Bioanal Chem
Pays: Germany
ID NLM: 101134327
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
received:
16
11
2021
accepted:
05
01
2022
revised:
20
12
2021
pubmed:
20
1
2022
medline:
21
9
2022
entrez:
19
1
2022
Statut:
ppublish
Résumé
We developed and validated a liquid chromatography high-resolution mass spectrometry method for the absolute quantification of 51 steroids for clinical analysis of human serum and, for the first time, peritoneal fluid. Data acquisition was performed in both targeted and untargeted mode simultaneously, thus allowing the accurate and precise quantification of the main components of the classical steroid pathways (17 steroids) as well as the analysis of 34 additional non-classical steroids. For targeted analysis, validation was performed according to FDA guidelines, resulting, among other parameters, in accuracy < 13% RSD and precision < 10% relative error, for both inter- and intra-day validation runs. By establishing steroid-specific response factors, the calibration curves of the targeted analytes can be extended to untargeted analytes. This approach opens novel possibilities for the post hoc analysis of clinical samples as the data can be examined for virtually any steroid even after data acquisition, enabling facile absolute quantification once a standard becomes available. We demonstrate the applicability of the approach to evaluate the differences in steroid content between peripheral serum and peritoneal fluid across the menstrual cycle phases, as well as the effect of the synthetic gestagen dienogest on the steroid metabolome.
Identifiants
pubmed: 35043262
doi: 10.1007/s00216-022-03881-3
pii: 10.1007/s00216-022-03881-3
pmc: PMC9482906
doi:
Substances chimiques
Progestins
0
Steroids
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
7461-7472Subventions
Organisme : H2020 European Research Council
ID : 101023999
Organisme : Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
ID : 198281
Organisme : Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
ID : IZSEZ0_189926/1
Informations de copyright
© 2022. The Author(s).
Références
Mol Cell Endocrinol. 2018 May 5;466:31-37
pubmed: 28918115
J Steroid Biochem Mol Biol. 2018 May;179:88-103
pubmed: 28962971
Acta Obstet Gynecol Scand. 2007;86(3):260-5
pubmed: 17364298
Endocr Rev. 2011 Feb;32(1):81-151
pubmed: 21051590
Clin Biochem. 2014 Oct;47(15):5-15
pubmed: 25086367
Electrophoresis. 2008 Jun;29(12):2706-13
pubmed: 18512681
Clin Chim Acta. 2017 Jul;470:115-124
pubmed: 28479316
Gynecol Oncol. 2020 Feb;156(2):400-406
pubmed: 31813586
Ann N Y Acad Sci. 2001 Sep;943:296-315
pubmed: 11594550
Clin Chem. 2017 Dec;63(12):1824-1835
pubmed: 28814383
J Clin Endocrinol Metab. 2014 Nov;99(11):E2188-97
pubmed: 25137424
J Steroid Biochem Mol Biol. 2017 Jan;165(Pt B):202-211
pubmed: 27339652
J Steroid Biochem Mol Biol. 2012 Apr;129(3-5):129-38
pubmed: 22210511
Maturitas. 2012 Apr;71(4):337-44
pubmed: 22364708
Hum Reprod. 1991 Oct;6(9):1233-7
pubmed: 1752923
Nucleic Acids Res. 2021 Jul 2;49(W1):W388-W396
pubmed: 34019663
Cancer Res. 2017 Jul 15;77(14):3951-3960
pubmed: 28381542
J Clin Endocrinol Metab. 1997 Dec;82(12):4252-7
pubmed: 9398749
Clin Biochem. 2016 Sep;49(13-14):989-97
pubmed: 27131495
Obstet Gynecol. 1982 Jun;59(6):687-92
pubmed: 7078906
J Steroid Biochem Mol Biol. 2016 Sep;162:70-9
pubmed: 26767303
Mod Pathol. 2017 Apr;30(4):563-576
pubmed: 28059101
Reprod Biomed Online. 2017 Nov;35(5):592-601
pubmed: 28693952